To evaluate the comparative efficacy of latanoprost monotherapy versus combined carteolol and pilocarpine therapy in patients with newly diagnosed glaucoma. Methods: Masked randomized prospective trial. This study included 51 patients (64 eyes) with newly diagnosed glaucoma or ocular hypertension. The cases were randomly divided into two treatment groups for administration of latanoprost 0.005 % once daily, or of car-teolol 2 % twice daily and pilocarpine 2 % twice daily. Mean diurnal intraocular pressure (IOP) was measured at baseline, week 2, week 4, and month 3 after the beginning of treat-ment. Changes in mean IOP from baseline to the 3-month visit were determined by an analy-sis of variance. Results: Mean diurnal IOP values were 25.
Purpose: To compare the intraocular pressure (IOP) lowering effect, diurnal variation and adverse ef...
PURPOSE: To compare the intraocular pressure (IOP) diurnal fluctuations of glaucoma patients treated...
International audienceBACKGROUND: Prospective, multicenter, randomized, double-masked trials have sh...
PURPOSE: To compare intraocular pressure (IOP) after adding either latanoprost or pilocarpine to...
Purpose: To compare 24-hour reduction in intraocular pressure (IOP) by latanoprost 0.005%, travopro...
Aims-To compare the effects on intraocular pressure (IOP) and side effects of monotherapy with eithe...
PurposeTo assess the intraocular pressure (IOP)-lowering effects and safety of a carteolol/latanopro...
Purpose:To assess the intraocular pressure (IOP)-reducing effect of latanoprost in treatment-naïve p...
BACKGROUND: Prospective, multicenter, randomized, double-masked trials have shown latanoprost instil...
Purpose: To compare the 24\u2013h mean IOP between bimatoprost and the fixed combination of latanopr...
To assess the noninferiority of a dorzolamide-timolol fixed combination (DTFC) versus latanoprost in...
Objective: To compare the effect of bimatoprost and the fixed combination of latanoprost and timolol...
Objective: To compare the effect of bimatoprost and the fixed combination of latanoprost and timolol...
Introduction and Purpose: Bimatoprost and the fixed combination of latanoprost with timolol maleate ...
Purpose: To compare the replacement of every drug with latanoprost 0.005% once a day in glaucomatous...
Purpose: To compare the intraocular pressure (IOP) lowering effect, diurnal variation and adverse ef...
PURPOSE: To compare the intraocular pressure (IOP) diurnal fluctuations of glaucoma patients treated...
International audienceBACKGROUND: Prospective, multicenter, randomized, double-masked trials have sh...
PURPOSE: To compare intraocular pressure (IOP) after adding either latanoprost or pilocarpine to...
Purpose: To compare 24-hour reduction in intraocular pressure (IOP) by latanoprost 0.005%, travopro...
Aims-To compare the effects on intraocular pressure (IOP) and side effects of monotherapy with eithe...
PurposeTo assess the intraocular pressure (IOP)-lowering effects and safety of a carteolol/latanopro...
Purpose:To assess the intraocular pressure (IOP)-reducing effect of latanoprost in treatment-naïve p...
BACKGROUND: Prospective, multicenter, randomized, double-masked trials have shown latanoprost instil...
Purpose: To compare the 24\u2013h mean IOP between bimatoprost and the fixed combination of latanopr...
To assess the noninferiority of a dorzolamide-timolol fixed combination (DTFC) versus latanoprost in...
Objective: To compare the effect of bimatoprost and the fixed combination of latanoprost and timolol...
Objective: To compare the effect of bimatoprost and the fixed combination of latanoprost and timolol...
Introduction and Purpose: Bimatoprost and the fixed combination of latanoprost with timolol maleate ...
Purpose: To compare the replacement of every drug with latanoprost 0.005% once a day in glaucomatous...
Purpose: To compare the intraocular pressure (IOP) lowering effect, diurnal variation and adverse ef...
PURPOSE: To compare the intraocular pressure (IOP) diurnal fluctuations of glaucoma patients treated...
International audienceBACKGROUND: Prospective, multicenter, randomized, double-masked trials have sh...